Ticker
KRROCompany Name
KORRO BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 44.63M | $ 115.1M | $ 159.74M |
3/31/2025 | $ 45.19M | $ 138.96M | $ 184.14M |
12/31/2024 | $ 44.77M | $ 160.41M | $ 205.18M |
9/30/2024 | $ 41.78M | $ 179.63M | $ 221.42M |
6/30/2024 | $ 38.46M | $ 198.08M | $ 236.54M |
3/31/2024 | $ 35.92M | $ 151.36M | $ 187.27M |
12/31/2023 | $ 33.21M | $ 169.91M | $ 203.12M |
9/30/2023 | $ 1.43M | $ 36.74M | $ 38.16M |
6/30/2023 | $ 27.81M | $ 45.41M | $ 73.22M |
3/31/2023 | $ 39.97M | $ 53.25M | $ 93.22M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for KORRO BIO INC is calculated as follows: Debt [ $ 2.24M ] + Equity [ $ 199.59M ]
(=) Inv. Capital [ $ 201.83M ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.14B |
average | $ 762.93M |
median | $ 306.23M |
std | $ 1B |